Literature DB >> 5416971

Delayed cutaneous hypersensitivity reactions to autologous extracts of Burkitt-lymphoma cells.

L Fass, R B Herberman, J Ziegler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5416971     DOI: 10.1056/NEJM197004022821404

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Delayed cutaneous hypersensitivity reactions to extracts of malignant and normal breast cells.

Authors:  C Alford; A C Hollinshead; R B Heberman
Journal:  Ann Surg       Date:  1973-07       Impact factor: 12.969

2.  Burkitt's Lymphoma: an unusual childhood tumor.

Authors:  J R Pickleman; F H Straus; E D Griffin; H M Reyes; R L Replogle
Journal:  Ann Surg       Date:  1972-07       Impact factor: 12.969

3.  Separation of lymphocytes and macrophages from suspensions of guinea pig peritonitis exudate cells using programmed gradient sedimentation.

Authors:  T G Pretlow; M E Pichichero; L Hyams
Journal:  Am J Pathol       Date:  1971-05       Impact factor: 4.307

4.  Progress in tropical pathology with special reference to Nigeria.

Authors:  G M Edington
Journal:  J Natl Med Assoc       Date:  1971-05       Impact factor: 1.798

5.  Delayed cutaneous sensitivity reactions to autologous Burkitt lymphoma protein extract. Results of a prospective two and a half year study.

Authors:  A Z Bluming; J L Ziegler; L Fass; R B Herberman
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

6.  Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells.

Authors:  M E Oren; R B Herberman
Journal:  Clin Exp Immunol       Date:  1971-07       Impact factor: 4.330

7.  Immune response and non-specific immunotherapy in melanoma.

Authors:  A A El-Domeiri
Journal:  Ann R Coll Surg Engl       Date:  1978-03       Impact factor: 1.891

8.  Immunity of Epstein-Barr virus in Hodgkin's disease preceded by infectious mononucleosis.

Authors:  P R Band; P H Levine; V C Patwardhan; T K Shnitka; H F Pabst
Journal:  Can Med Assoc J       Date:  1973-01-20       Impact factor: 8.262

9.  Purified plasminogen activating factor produced by malignant lymphoid cells abrogates lymphocyte cytotoxicity.

Authors:  S K Sundar; J Bergeron; J Menezes
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

10.  [Leukocyte adhesion inhibition: a simple in-vitro test for the detection of tumor-specific immunity and blocking serum factors in children with malignant neoplasms].

Authors:  F Lampert; E Dietmair
Journal:  Infection       Date:  1973       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.